FindTrial
Sign In

Protective effects of combined eptifibatide and ticagrelor in patients with unstable angina undergoing percutaneous coronary intervention

Protective effects of combined eptifibatide and ticagrelor in patients with unstable angina undergoing percutaneous coronary intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096895
Enrollment
Unknown
Registered
2025-02-08
Start date
2025-02-08
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable angina

Interventions

Ticagrelor group:None
Eptifibatide and ticagrelor group:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with unstable angina pectoris and elective coronary revascularization PCI were selected from the Department of Cardiology of our hospital, and unstable angina included initial angina, worsening exertional angina, and resting angina with or without ECG ischemic changes.

Exclusion criteria

Exclusion criteria: 1.First admission with positive troponin; 2.Thrombocytopenia (PLT<50×10^9/L) or decreased hemoglobin (Hb<10g/dL); 3.Recent history of bleeding; 4.Liver and kidney dysfunction, peptic ulcers, hematological diseases, malignant tumors.

Design outcomes

Primary

MeasureTime frame
MACE and hemorrhage;—

Secondary

MeasureTime frame
Platelet function;hs-TnT;NT-proBNP;CRP;H-FABP;—

Countries

China

Contacts

Public ContactLin ling

The First Affiliated Hospital of Soochow University

njulinglin@163.com+86 512 67972087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026